George L Sing
Director · Regeneron Pharmaceuticals, Inc. (REGN)
sold: $20,376,358 · planned sales: $1,917,952
| Date | Trade | Shares | Avg. price | Value | Filing |
|---|---|---|---|---|---|
| November 17, 2026 | Planned sale | 1,000 | — | $957,687 | SEC |
| November 16, 2026 | Planned sale | 1,000 | — | $960,264 | SEC |
| November 2, 2026 | Sale notice filed | 21,129 | $964.38 | $20,376,358 | SEC |
Shown: open-market purchases and sales (Form 4, codes P and S) and notices of planned sales (Form 144), values as filed. Not shown: grants, tax withholding, gifts and option exercises — they are not trades. A disclosed trade does not show how the person rates the company and is not a recommendation.
